The impact of a positive urine culture before ureteroscopy and laser lithotripsy in patients with ureteral/renal stones: Results from a single centre series

by L. Villa, E. Ventimiglia, G. Fallara, M. Menean, P. Capogrosso, R. Matloob, A. Briganti, F. Montorsi, A. Salonia
Published 2020-07-01

Recovery from transient urinary incontinence post-HoLEP – findings from a prospective trial (EXPHO)

by P. Capogrosso, F. Pellegrino, G. Fallara, G. Sorce, W. Cazzaniga, L. Candela, N. Schifano, R. Matloob, L. Boeri, F. Deho’, C. Abbate, A. Salonia, F. Montorsi
Published 2020-10-01

Patients presenting with lower urinary tract symptoms who most deserve to be investigated for bladder neck sclerosis

by N. Schifano, P. Capogrosso, R. Matloob, L. Boeri, L. Candela, G. Fallara, A. Costa, E. Pozzi, F. Belladelli, W. Cazzaniga, C. Abbate, F. Montorsi, A. Salonia
Published 2020-10-01

Do postoperative benefits continue after 10 years from Holmium Laser Enucleation of the Prostate (HoLEP)?

by G. Fallara, P. Capogrosso, L. Candela, N. Schifano, F. Pellegrino, W. Cazzaniga, L. Boeri, F. Belladelli, F. Dehò, R. Matloob, V. Mirone, A. Salonia, F. Montorsi
Published 2020-07-01

The importance of sign and symptoms assessment in patients with metastatic renal cell carcinoma: implications for cytoreductive nephrectomy

by A. Larcher, G. Fallara, G. Rosiello, G. Basile, C. Re, G. Baiamonte, S. Agnesi, D. Cignoli, G. Colandrea, A. Briganti, R. Bertini, A. Salonia, F. Montorsi, U. Capitanio
Published 2020-10-01

Recovery from transient urinary incontinence post-HoLEP – findings from a prospective trial (ExpHo)

by P. Capogrosso, N. Schifano, F. Pellegrino, L. Candela, G. Fallara, G. Sorce, W. Cazzaniga, R. Matloob, L. Boeri, F. Deho’, C. Abate, V Mirone, A. Salonia, F. Montorsi
Published 2020-07-01

SHBG levels in primary infertile men: A critical interpretation in the everyday clinical practice

by L. Boeri, P. Capogrosso, W. Cazzaniga, E. Ventimiglia, E.P. Pozzi, F. Belladelli, A. Baudo, N. Schifano, L. Candela, G. Fallara, C. Abate, V. Mirone, E. Montanari, F. Montorsi, A. Salonia
Published 2020-07-01

Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function

by G. Fallara, A. Larcher, G. Rosiello, G. Basile, D. Cignoli, G. Colandrea, A. Martini, W. Cazzaniga, C.A. Bravi, M. Bandini, G. Baiamonte, A. Briganti, A. Salonia, R. Bertini, F. Montorsi, U. Capitanio
Published 2020-10-01

Is focal ablation as effective as hemi-ablation? Analysis of treatment patterns over 12 years from a high volume centre for focal therapy

by A. Stabile, G. Gandaglia, N. Fossati, G. Sorce, S. Scuderi, G. Fallara, V. Cucchiara, E. Zaffuto, D. Robesti, F. Pellegrino, C. Orczyk, F. Giganti, H.U. Ahmed, M. Emberton, A. Briganti, F. Montorsi, C.M. Moore
Published 2020-07-01

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: Results from the national cancer database

by A. Martini, J. Pfail, U.G. Falagario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, A. Necchi, F. Montorsi, A. Briganti, J. Daza, P.J. Treacy, M.D. Galsky, J.P. Sfakianos
Published 2020-07-01

Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy

by A. Stabile, G. Gandaglia, N. Fossati, A. Gallina, C.A. Bravi, E. Mazzone, A. Martini, F. Barletta, S. Scuderi, G. Fallara, V. Cucchiara, E. Zaffuto, R. Daniele, F. Pellegrino, C. Orczyk, F. Giganti, H.U. Ahmed, M. Emberton, A. Briganti, F. Montorsi, C.M. Moore
Published 2020-10-01

Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial

by B. Marco, A. Martini, J. Pfail, G. Gandaglia, N. Fossati, S. Scuderi, G. Fallara, F. Barletta, D. Robesti, A. Rizzo, G. Basile, C.A. Bravi, G. Rosiello, L. Nocera, A. Stabile, A. Gallina, A. Salonia, F. Montorsi, A. Briganti, M.D. Galsky, W.K. Oh
Published 2020-10-01

Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H

by G. Gandaglia, A. Heidenreich, D. Pfister, S. Shariat, B. Grubmuller, G. Motterle, G. Devos, D. Robesti, F. Scalvi, G. Fallara, A. Pellegrino, C. Berghen, W. Everaerts, N. Fossati, S. Scuderi, A. Martini, P.I. Karakiewicz, F. Montorsi, S. Joniau, R. Karnes, F. Barletta, C.A. Bravi, A. Briganti
Published 2020-10-01

The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with ol...

by E. Mazzone, A. Heidenreich, G. Gandaglia, D. Pfister, S. Shariat, B. Grubmuller, N. Fossati, A. Stabile, S. Scuderi, F. Pellegrino, G. Sorce, G. Fallara, G. Rosiello, A. Martini, M. Bandini, V. Cucchiara, E. Zito, A. Pellegrino, P.I. Karakiewicz, M. Moschini, R.J. Karnes, F. Montorsi, A. Briganti
Published 2020-10-01

The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer

by D. Cannoletta, G. Gandaglia, D. Pfister, S. Shariat, B. Grubmuller, N. Fossati, A. Stabile, S. Scuderi, F. Pellegrino, G. Sorce, G. Fallara, A. Martini, V. Cucchiara, D. Robesti, A. Rizzo, F. Scalvi, A. Gallina, E. Mazzone, P.I. Karakiewicz, R.J. Karnes, F. Montorsi, A. Briganti, A. Heidenreich
Published 2020-10-01

The inverse correlation between obesity and mortality in patients with metastatic castration resistant prostate cancer: Results from the control arms of ASCENT2, MAINSAL and VENICE...

by D. Cignoli, A. Martini, J.P. Sfakianos, G. Gandaglia, N. Fossati, A. Salonia, F. Barletta, S. Scuderi, D. Robesti, C.A. Bravi, E. Mazzone, G. Rosiello, G. Fallara, L. Nocera, G.O. Cirulli, A. Stabile, A. Briganti, F. Montorsi, W.K. Oh, E.D. Gallagher, M.D. Galsky
Published 2020-10-01

Initial negative multi-parametric MRI with concomitant negative biopsy: Are true negative findings confirmed over time? Results from a single institution series

by A. Stabile, N. Fossati, E. Zaffuto, G. Gandaglia, D. Robesti, D. Cannoletta, M. Menean, E. Mazzone, S. Comana, V. Cucchiara, G. Fallara, V. Cucchiara, P. Dell’oglio, A. Martini, M. Moschini, A. Rizzo, V. Mirone, A. Necchi, A. Salonia, P.I. Karakiewicz, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-07-01

Are men with low risk prostate cancer but high PIRADS score lesions at mp-MRI still candidate for active surveillance? Results from a large, multi-institutional radical prostatecto...

by A. Stabile, R.J. Karnes, G. Motterle, N. Fossati, G. Gandaglia, F. Barletta, S. Scuderi, V. Cucchiara, G. Fallara, D. Robesti, D. Cannoletta, S. Comana, F. Pellegrino, E. Mazzone, G. Rosiello, C.A. Bravi, P. Dell’Oglio, A. Salonia, G. Brembilla, A. Esposito, F. Montorsi, F. De Cobelli, A. Briganti
Published 2020-07-01

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database

by G. Sorce, A. Martini, J. Pfail, U.G. Falgario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, D. Cignoli, G. Basile, L. Nocera, G. Rosiello, E. Mazzone, C.A. Bravi, A. Necchi, F. Montorsi, A. Briganti, M.D. Galsky, J.P. Sfakianos
Published 2020-10-01

A prospective, randomized, phase 3 trial assessing the impact of early Dorsal Venous Complex (eDVC) ligation on urinary continence recovery after robot-assisted radical prostatecto...

by F. Montorsi, C.A. Bravi, G. Fallara, G. Rosiello, E. Mazzone, L. D’ambrosio, A. Gallina, A. Martini, G. Gandaglia, N. Fossati, V. Cucchiara, L. Nocera, E. Zaffuto, F. Barletta, S. Scuderi, D. Robesti, A. Rizzo, D. Cannoletta, E. Zito, N. Longo, V. Mirone, P.I. Karakiewicz, A. Briganti
Published 2020-07-01